These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14626986)

  • 1. Protecting protected speech: First Amendment taxonomy and the Food and Drug Administration's regulation of "enduring materials.".
    Gilman DJ
    Food Drug Law J; 2003; 58(3):463-71. PubMed ID: 14626986
    [No Abstract]   [Full Text] [Related]  

  • 2. The First Amendment and the Food and Drug Administration's regulation of labeling and advertising: three proposed reforms.
    Kahan JS; Shapiro JK
    Food Drug Law J; 2003; 58(3):353-64. PubMed ID: 14626983
    [No Abstract]   [Full Text] [Related]  

  • 3. Courts are arriving at a consensus on Food and Drug Administration speech regulation.
    Samp RA
    Food Drug Law J; 2003; 58(3):313-29. PubMed ID: 14626232
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: can we talk? About Food and Drug Regulation and the First Amendment.
    Cohen MN
    Food Drug Law J; 2003; 58(4):741-56. PubMed ID: 15027458
    [No Abstract]   [Full Text] [Related]  

  • 5. The First Amendment and federal court deference to the Food and Drug Administration: The Times They Are A-Changin'.
    Basile EM; Gross M
    Food Drug Law J; 2004; 59(1):31-44. PubMed ID: 15190924
    [No Abstract]   [Full Text] [Related]  

  • 6. The Food and Drug Administration's regulation of prescription drug manufacturer speech: a First Amendment analysis.
    Evans GW; Friede AI;
    Food Drug Law J; 2003; 58(3):365-437. PubMed ID: 14626984
    [No Abstract]   [Full Text] [Related]  

  • 7. Ripe for revision: reassessing the constitutionality of Food and Drug Administration restrictions on protected speech.
    Gibbs JN; Ferrari PL; Murphy AM;
    Food Drug Law J; 2003; 58(3):331-45. PubMed ID: 14626233
    [No Abstract]   [Full Text] [Related]  

  • 8. Public notice from the Food & Drug Administration's Center for Devices and Radiological Health.
    Ostomy Wound Manage; 1997 Oct; 43(9):84. PubMed ID: 9369748
    [No Abstract]   [Full Text] [Related]  

  • 9. The Food and Drug Administration's import alerts appear to be "misbranded".
    Humphrey CM
    Food Drug Law J; 2003; 58(4):595-612. PubMed ID: 15027452
    [No Abstract]   [Full Text] [Related]  

  • 10. Going 90 in a 55 M.P.H. speed zone: reprocessing of used single-use medical devices and the Food and Drug Administration's non-enforcement of the Food, Drug, and Cosmetic Act.
    Karst KR
    Food Drug Law J; 2001; 56(1):57-76. PubMed ID: 11942351
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug manufacturers' First Amendment right to advertise and promote their products for off-label use: avoiding a pyrrhic victory.
    Blackwell AE; Beck JM;
    Food Drug Law J; 2003; 58(3):439-62. PubMed ID: 14626985
    [No Abstract]   [Full Text] [Related]  

  • 12. Protecting the public health by strengthening the Food and Drug Administration's authority over tobacco products.
    Myers ML
    N Engl J Med; 2000 Dec; 343(24):1806-9. PubMed ID: 11114323
    [No Abstract]   [Full Text] [Related]  

  • 13. Hiding behind agency discretion: the Food and Drug Administration's personal use drug importation policy.
    Reichertz PS; Friend MS
    Cornell J Law Public Policy; 2000; 9():493-521. PubMed ID: 11067734
    [No Abstract]   [Full Text] [Related]  

  • 14. Foreign Establishment Registration and United States agent requirements.
    Nolte CJ; McNamara-Cullinane M
    Med Device Technol; 2002 Dec; 13(10):32-3. PubMed ID: 12575528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WLF and the two-click rule: the First Amendment inequity of the Food and Drug Administration's regulation of off-label drug use information on the Internet.
    Ward SM
    Food Drug Law J; 2001; 56(1):41-56. PubMed ID: 11942350
    [No Abstract]   [Full Text] [Related]  

  • 16. Constitutional protection of commercial speech under the Central Hudson test as applied to health claims.
    Schramm MJ
    Food Drug Law J; 1996; 51(2):323-9. PubMed ID: 11822325
    [No Abstract]   [Full Text] [Related]  

  • 17. The US Food and Drug Administration's efforts to support ophthalmology clinical trials.
    Eydelman MB
    JAMA Ophthalmol; 2014 Dec; 132(12):1391-2. PubMed ID: 25171671
    [No Abstract]   [Full Text] [Related]  

  • 18. The Food and Drug Administration's regulation of risk disclosure for implantable cardioverter defibrillators: has technology outpaced the Agency's regulatory framework?
    Basile EM; Lorell BH
    Food Drug Law J; 2006; 61(2):251-72. PubMed ID: 16903031
    [No Abstract]   [Full Text] [Related]  

  • 19. Anchors away: the Food and Drug Administration's use of disgorgement abandons legal moorings.
    Vodra WW; Levine AN
    Food Drug Law J; 2004; 59(1):1-30. PubMed ID: 15190923
    [No Abstract]   [Full Text] [Related]  

  • 20. The Food and Drug Administration's regulation of dental products.
    Pinco RG; Rubin PD
    J Clin Dent; 1995; 6(3):165-9. PubMed ID: 8615957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.